Maxonis Ltd.

About

Offices

Q&A

What is Maxonis Ltd.'s primary focus?

Maxonis Ltd. is a biotechnology company focused on developing groundbreaking solutions for nerve repair, specifically advancing a regenerative therapy to restore motor and sensory function.

What is the name of Maxonis Ltd.'s primary product?

Maxonis Ltd.'s primary product is LDP-916, a first-in-class peptide hydrogel therapy designed to regenerate nerve tissue.

Which medical conditions does Maxonis Ltd. aim to address with its technology?

Maxonis Ltd. aims to address unmet medical needs in Peripheral Nerve Injury (PNI), Spinal Cord Injury (SCI), and Traumatic Brain Injury (TBI).

When was Maxonis Ltd. founded?

Maxonis Ltd. was founded in 2013.

Where is Maxonis Ltd. headquartered?

Maxonis Ltd. is headquartered in Tel Aviv, Israel.

Who are the co-founders of Maxonis Ltd.?

The co-founders of Maxonis Ltd. are Itay Itzhaky (Co-Founder & CEO), Prof. Shimon Rochkind, MD, PhD (Co-Founder & CMO), and Dr. Arie Goldlust PhD (Co-Founder & CTO).

Team · 12

Itay Itzhaky

Founder · Co-Founder & CEO

Prof. Shimon Rochkind, MD, PhD

Founder · Co-Founder & CMO

Dr. Arie Goldlust PhD

Founder · Co-Founder & CTO

Dr. Lilach Weisz, PhD

VP Operation

Dr. Mara Almog, PhD

R&D Director

Yafit Keret

CFO

Elia Spector

VP of People & Marketing

Asher Kachlon

R&D Manager

Dr. Jim Schuster MD, PhD

Scientific & Clinical Advisory Board Member

Professor Eric L. Zager, MD

Scientific & Clinical Advisory Board Member

Prof. Dr. Thomas Kretschmer, MD

Scientific & Clinical Advisory Board Member

Jim Martucci, MSc.

Medical Device Technology Consultant (Scientific & Clinical Advisory Board)

Sectors & technology